Updates are available Correction dated 2020-05-14
Click to view Correction: https://doi.org/10.1038/s41467-020-16452-w
-
Authors
Wang, Chunyan
Li, Wentao http://orcid.org/0000-0002-7114-762X
Drabek, Dubravka http://orcid.org/0000-0002-9781-1701
Okba, Nisreen M. A. http://orcid.org/0000-0002-2394-1079
van Haperen, Rien
Osterhaus, Albert D. M. E.
van Kuppeveld, Frank J. M.
Haagmans, Bart L. http://orcid.org/0000-0001-6221-2015
Grosveld, Frank
Bosch, Berend-Jan http://orcid.org/0000-0002-3864-232X
- License Information
-
More Information
Article History
Received: 27 March 2020
Accepted: 23 April 2020
First Online: 4 May 2020
Change Date: 14 May 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: A patent application has been filed on 12 March 2020 on monoclonal antibodies targeting SARS-CoV-2 (United Kingdom patent application no. 2003632.3; patent applicants: Utrecht University, Erasmus Medical Center and Harbour BioMed). F.G., D.D., and R.v.H. are non-substantial interest shareholders in Harbour Biomed and were part of the team that generated the mice.
